June 2020 | In response to the global outbreak of COVID-19, CrossLife Technologies has developed the IsoTARATM COVID-19 Colorimetric Assay to perform near point-of-care where sample extraction is not necessary. The IsoTARA amplification processes...
Read more
June 2020 | In response to the global outbreak of the novel coronavirus disease (COVID-19), CrossLife Technologies has developed a real-time RT-PCR test, CLT™ SARS-CoV-2 qRT-PCR Assay, intended for the qualitative detection of nucleic acid...
Read more
August 2018 | CrossLife has recently been awarded a Phase II Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of HIV virus. Point-of-Care Rapid RNA test for...
Read more
March 2017 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay Development...
Read more
CrossLife was on an NCATS feature story about SBIR grantees and NIH I-Corps training. https://ncats.nih.gov/pubs/features/sbir-i-corps NIH I-Corps Training Helps NCATS-Supported Companies Find Their Way Learning what customers want I-Corps...
Read more
January 2017 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of Zika virus.
Read more October 2016 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on two Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay...
Read more
July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Detection of Chikungunya at the Point of Care ...
Read more
July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for Point-of-Care Rapid RNA test for HIV ...
Read more
June 2016 | We have successfully finished the NIH I-Corps entrepreneur immersion program (March 2016- May 2016). We have assembled an I-Corp team composed of an experienced industry expert who is a Key Opinion Leader in the diagnostics industry...
Read more
May 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NCATS for Point-of-Care Rapid RNA Diagnosis of Influenza Virus ...
Read more
March 2016 | NIH I-Corps | CrossLife has been selected for the highly competitive NIH I-Corps entrepreneur immersion training program. The goal of the program is to identify customers and markets for our point-of-care dengue diagnostic, and to...
Read more